N-Acetyl Cysteine

• NAC has been shown to reduce the symptoms of both schizophrenia^[15] and bipolar disorder^[16] in two placebo controlled trials.

^ Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI (September 2008). "N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial". Biol. Psychiatry 64 (5): 361–8. doi:10.1016/j.biopsych.2008.03.004. PMID 18436195. http://linkinghub.elsevier.com/retrieve/pii/S0006-3223(08)00270-9.

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T4S-4SBRTPW-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0525028f4260826b34dc2ef39c05bb98

^ Berk M, Copolov DL, Dean O, et al (September 2008). "N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial". Biol. Psychiatry 64 (6): 468–75. doi:10.1016/j.biopsych.2008.04.022. PMID 18534556.